Immune Tolerance Network (ITN)
Immune Tolerance Network (ITN)
Explore linked clinical trials.7 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Belimumab With Rituximab for Primary Membranous Nephropathy | Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Urogenital Diseases, autoimmune disease, glomerulonephritis, immune system disorder, kidney disorder, membranous glomerulonephritis, nephritis, nephrosis, nephrotic syndrome, urinary system disorder | Recruiting | Phase 2 | 2026-09-18 | NCT03949855 | |
| Type 1 Diabetes Extension Study | Insulin Resistance, Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose intolerance, glucose metabolism disease, hyperglycemia, hyperinsulinism, immune system disorder, metabolic disease, type 1 diabetes mellitus | Recruiting | Not stated | 2026-09-18 | NCT02734277 | |
| Efficacy of Tezepelumab in Peanut Oral Immunotherapy | Hypersensitivity, Immediate, Nut and Peanut Hypersensitivity, Peanut Hypersensitivity, food allergy, immune system disorder | Recruiting | Phase 2 | 2026-09-16 | NCT07015996 | |
| Daratumumab in Primary Antiphospholipid Syndrome | antiphospholipid syndrome, autoimmune disease, immune system disorder | Recruiting | Phase 1 / Phase 2 | 2026-09-16 | NCT05671757 | |
| Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS) | CNS demyelinating autoimmune disease, Chronic Disease, Disease Attributes, Pathologic Processes, Pathological Conditions, Signs and Symptoms, autoimmune disease, autoimmune disorder of the nervous system, chronic progressive multiple sclerosis, demyelinating disease, immune system disorder, multiple sclerosis, nervous system disorder, relapsing-remitting multiple sclerosis | Recruiting | Phase 3 | 2026-09-16 | NCT04047628 | |
| Carfilzomib and Belatacept for Desensitization | Highly Sensitized Prospective Kidney Transplant Recipients | Active, not recruiting | Phase 1 / Phase 2 | 2026-04-08 | NCT05017545 | |
| Vaginal Microbiome Exposure and Immune Responses in C-section Infants | Hypersensitivity, Immediate, Respiratory Hypersensitivity, asthma, bronchial disorder, immune system disorder, lung disorder, obstructive lung disease, respiratory system disorder | Active, not recruiting | Early phase 1 | 2025-11-05 | NCT03567707 |